Eli Lilly CEO Dave Ricks took a stand against Trump's tariffs in a Q1 earnings call. The medicine company has strong operations for obesity and weight loss drugs in Ireland.

But international agreements are notoriously difficult to enforce, and pharma companies and patient advocates who were ...

Trump hosted top CEOs at the White House to announce over $8 trillion in U.S. investments. From AI chips to steel, here’s who ...

Seven months after the FDA approved the reintroduction of Roche's eye implant Susvimo, the US agency has expanded its approved use to include treatment for diabetic macular edema, the primary ...

President Trump wants to bring manufacturing back to the U.S. These companies say they're investing in domestic factories.

President Trump’s proposed 25% tariff on pharmaceutical imports, largely from Ireland, could raise U.S. drug costs by nearly ...

Swiss chemicals giant Clariant does not intend to increase US investments, unlike pharma firms Roche and Novartis.

Positive recommendation based on clinical, real-world and bioequivalence data supporting feasibility and safety of Phesgo's ...

Donald Ingber, MD, PhD; Miguel Forte, MD, PhD; Ali Pashazadeh, MRCS, MBA; and Adam Inche, PhD, MBA go behind the headlines to ...

Detailed price information for Regeneron Pharmaceuticals (REGN-Q) from The Globe and Mail including charting and trades.

Basel, 29 April 2025 - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that the U.S. Food and Drug Administration (FDA) granted Breakthrough Device Designation for the VENTANA® TROP2 (EPR20043) ...